Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.
Xu
Binghe
B
Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, 100021 Beijing, China. bhxu@hotmail.com
Jiang
Zefei
Z
Shao
Zhimin
Z
Wang
Jiayu
J
Feng
Jifeng
J
Song
Shuping
S
Chen
Zhendong
Z
Gu
Kangsheng
K
Yu
Shiying
S
Zhang
Yiping
Y
Wang
Chuan
C
Zhang
Fengchun
F
Yang
Junlan
J